The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 2008, 181, 3456 -3463
Copyright © 2008 by The American Association of Immunologists, Inc.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamada, S.
Right arrow Articles by Matsuzaki, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamada, S.
Right arrow Articles by Matsuzaki, G.

IL-17A Produced by {gamma}{delta} T Cells Plays a Critical Role in Innate Immunity against Listeria monocytogenes Infection in the Liver1

Satoru Hamada*,{ddagger}, Masayuki Umemura*,§, Takeru Shiono*,§, Kensho Tanaka*,||, Ayano Yahagi*,§, M. Dilara Begum*,§, Kiyotetsu Oshiro*,¶, Yuko Okamoto*,§, Hisami Watanabe{dagger}, Kazuyoshi Kawakami#, Christina Roark**, Willi K. Born**, Rebecca O'Brien**, Koichi Ikuta{dagger}{dagger}, Hiromichi Ishikawa*, Susumu Nakae*, Yoichiro Iwakura*, Takao Ohta{ddagger} and Goro Matsuzaki2,*,§

* Molecular Microbiology Group and {dagger} Immunobiology Group, Center of Molecular Biosciences, {ddagger} Division of Child Health and Welfare, § Division of Host Defense and Vaccinology, Division of Digestive and General Surgery, Graduate School of Medicine, and || Department of Bioscience and Biotechnology, Faculty of Agriculture, University of the Ryukyus, Okinawa, Japan; # Division of Microbiology and Immunology, Department of Medical Technology, School of Health Sciences, Faculty of Medicine and Infection Control Center, Tohoku University, Miyagi, Japan; ** Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206; {dagger}{dagger} Laboratory of Biological Protection, Department of Biological Responses, Institute for Virus Research, Kyoto University, Kyoto, Japan; * Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and * Center for Experimental Medicine, Institution of Medical Science, University of Tokyo, Tokyo, Japan


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
IL-17A is originally identified as a proinflammatory cytokine that induces neutrophils. Although IL-17A production by CD4+ Th17 T cells is well documented, it is not clear whether IL-17A is produced and participates in the innate immune response against infections. In the present report, we demonstrate that IL-17A is expressed in the liver of mice infected with Listeria monocytogenes from an early stage of infection. IL-17A is important in protective immunity at an early stage of listerial infection in the liver because IL-17A-deficient mice showed aggravation of the protective response. The major IL-17A-producing cells at the early stage were TCR {gamma}{delta} T cells expressing TCR V{gamma}4 or V{gamma}6. Interestingly, TCR {gamma}{delta} T cells expressing both IFN-{gamma} and IL-17A were hardly detected, indicating that the IL-17A-producing TCR {gamma}{delta} T cells are distinct from IFN-{gamma}-producing {gamma}{delta} T cells, similar to the distinction between Th17 and Th1 in CD4+ T cells. All the results suggest that IL-17A is a newly discovered effector molecule produced by TCR {gamma}{delta} T cells, which is important in innate immunity in the liver.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Interleukin-17A was originally reported as a product of CD4+ {alpha}β T cells, whose production is regulated by IL-23, a heterodimeric cytokine consisting of an unique p19 subunit and a p40 subunit that is shared with IL-12 (1, 2). IL-17A induces neutrophils through the induction of cytokines important in granulopoiesis (G-CSF) and neutrophil chemotaxis (CXCL1/KC and CXCL8/IL-8) (3), and it is essential for not only development of autoimmune disease such as experimental allergic encephalomyelitis, but also protection against pathogens such as Klebsiella pneumoniae and Candida sp (4, 5, 6). The participation of IL-17A has also been reported in infection with the intracellular bacteria Mycobacterium tuberculosis and Mycobacterium bovis BCG (7, 8).

Recently, IL-17A-producing CD4+ T cells, the Th17 cells, have been shown to be distinct from classical Th1 and Th2 cells. Interestingly, the development of Th17 cells was inhibited by IFN-{gamma} and IL-4. In addition, TGF-β and IL-6 were found to be essential in the commitment of naive T cells to Th17 through the induction of IL-23 receptor (9, 10, 11, 12).

CD4+ T cells are not the only IL-17A-producing T cell population. We demonstrated that Fas-signaling induced IL-17A-producing TCR {gamma}{delta} T cells (13). IL-17A-producing CD4–CD8– TCR {gamma}{delta} and TCR {alpha}β T cells were also reported in adhesion molecule deficient mice, and were named Tn for neutrophil-regulatory T cells (14). The majority of the IL-17A-producing T cells in mycobacteria-infected mice were also TCR {gamma}{delta} T cells (7, 8). We therefore speculated that TCR {gamma}{delta} T cells with functions equivalent to Th17 cells exist just as TCR{gamma}{delta} T cells with type 1 (IFN-{gamma}) (15, 16), type 2 (IL-4, IL-10) (17, 18), or type 3 (TGF-β) cytokine profiles exist (19, 20), and that the IL-17A-producing TCR {gamma}{delta} T cells participate in protective immunity before appearance of Th17.

In this study, we demonstrate that TCR {gamma}{delta} T cells with restricted V{gamma} usage develop into IL-17A producing T cells and participate in the innate immune response against the intracellular bacterial pathogen L. monocytogenes at an early stage of infection. The IL-17A produced by the TCR {gamma}{delta} T cells was indispensable in innate immunoprotection against the infection.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Animals

Wild-type C57BL/6 mice were purchased from Japan SLC. The IL-17A–/– mice (21), the TCR C{delta}–/– mice (22) of C57BL/6 background, and the V{gamma}4/6–/– mice (23) were back-crossed more than eight times to the C57BL/6 mice. To generate the bone marrow (BM)3 chimeras, the IL-17A–/– recipient mice were irradiated with 9 Gy using an x-ray source, then injected i.v. with 2 x 107 BM cells from wild-type, TCR C{delta}–/–, IL-17A–/– mice, or 1:1 mixture of TCR C{delta}–/– and IL-17A–/– BM cells. The mice were maintained under conventional conditions for 5 wk until analysis. Experiments were conducted according to the Institutional Ethical Guidelines for Animal Experiments and the Safety Guideline for Living Modified Organism Experiments of the University of the Ryukyus under approval of the Animal Experiments Safety and Ethics Committee and the Living Modified Organism Experiments Safety Committee of the University of the Ryukyus, respectively.

Microorganisms and bacterial infection

L. monocytogenes strain EGD was inoculated in C57BL/6 mice, fresh isolates were obtained from infected spleens, grown in tryptic soy broth (Difco), resuspended in PBS, and stored at –80°C in small aliquots until use. Mice were infected by i.p. inoculation of 5 x 104 CFU of L. monocytogenes. Heat killed L. monocytogenes were obtained by incubating viable L. monocytogenes at 70°C for 2 h.

Cell preparation

Liver mononuclear cells were prepared as described previously (24). Splenocytes were prepared by forcing minced spleens through stainless steel mesh and were used after RBC lysis. To enrich TCR {gamma}{delta} T cells, cells were passed through the nylon wool columns. Then the TCR {gamma}{delta} T cells were enriched by magnetic cell separation system (autoMACS; Miltenyi Biotec) by using biotin- or FITC-conjugated anti-TCR C{delta} mAb (GL-3; BD Biosciences) and streptavidin or anti-FITC microbeads (Miltenyi Biotec), respectively.

Gene expression analysis by RT-PCR

Using Trizol reagent (Invitrogen) total RNA was extracted. First strand cDNA was synthesized using reverse transcriptase (Superscript; Invitrogen). The first-strand cDNA was amplified by PCR using Taq polymerase (Takara Shuzo). Real-time PCR amplifications were analyzed using the iCycler iQ and the Real-Time PCR Optical System Software version 3.0 (Bio-Rad). The {Delta}Ct method was used to normalize expression level of transcripts by β-actin expression level as previously reported (7). The specific primers were as follows: IL-17A sense (5'-GAT CAG GAC GCG CAA ACA TG-3'), IL-17A antisense (5'-AGT TTG CTG AGA AAC GTG GG-3'), β-actin sense (5'-TGG AAT CCT GTG GCA TCC ATG AAA C-3'), β-actin antisense (5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3').

In some experiments cDNA was amplified with TCR V{gamma} or V{delta} sense primers and C{gamma} or C{delta} antisence primers (25). PCR products were electrophoresed through a 1.8% agarose gel, stained with ethidium bromide, and photographed using the Gel-Documentation system (Bio-Rad).

FACS analysis

To detect intracellular cytokine expression, cells were cultured with 1 µg/ml calcium ionophore, 25 ng/ml PMA, and brefeldin A for 4 h. Cells were first stained for surface Ags and then with Cytofix/Cytoperm (BD Biosciences) according to the manufacturer’s instructions. Intracellular cytokine staining was performed using biotin-conjugated anti-C{delta} mAb (GL3; BD Biosciences) followed by allophycocyanin-conjugated streptavidin, FITC-conjugated anti-TCR V{gamma}4 (BD Biosciences), FITC-conjugated anti-TCR V{gamma}1 (2.11, provided by Dr. P. Pereira, Institute Pasteur, Paris, France), PE-conjugated anti-IL-17A, and PE-conjugated anti-IFN-{gamma} mAb (BD Biosciences). Nomenclature of V{gamma} is according to Heilig and Tonegawa (26). In some experiments cells were stained first with FITC-conjugated anti-C{delta} mAb (GL3; BD Biosciences) and then stained with biotin-conjugated 17D1 mAb (27) followed by allophycocyanin-conjugated streptavidin and PE-conjugated anti-IL-17A mAb. The stained cells were analyzed with a flowcytometer FACSCalibur (BD Biosciences).

Bacterial counts in organs

The L. monocytogenes-infected mice were sacrificed on day 1, day 3, and day 5 of the infection, and the livers were removed. The organs were homogenized in saline, and the bacterial number in each organ was determined.

Histopathology

The L. monocytogenes-infected mice were sacrificed on day 5 of the infection. The liver was fixed in buffered formalin and embedded in paraffin, and sections were stained with H&E. The stained sections were examined under a BX41 microscope (Olympus) equipped with x4/0.13 or x20/0.50 objectives. Images were acquired with DP70 digital camera and DP software (Olympus). The liver was also embedded in OCT compound (Sakura) frozen in dry ice-acetone, thin sections were stained with allophycocyanin-conjugated anti-CD3 mAb and Alexa 488-conjugated anti-CD11b mAb, and analyzed under Radiance 2100 confocal laser scanning microscope (Bio-Rad) equipped with x20/0.70 objective. The images of confocal scanning microscope were acquired with LaserSharp 2000 software (BioRad) and merged using Adobe Photoshop software.

Serum alanine aminotransferase (ALT) levels

Serum were prepared from the mice on day 1 and day 5 after L. monocytogenes infection and measured by Transamylase C-2 kit (WAKO) according to the manufacturer’s instructions.

Statistics

Data were statistically evaluated by Student’ t test using Statwork Software (Cricket Software). A p-value of <0.05 was considered to indicate statistical significance.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Expression of IL-17A in the liver of L. monocytogenes-infected mice

To determine the involvement of IL-17A in the innate immune response against L. monocytogenes infection, we analyzed the expression of IL-17A in the liver of Listeria-infected mice. We found that IL-17A mRNA expression increased from day 1 and maintained high levels of expression to day 5 in the liver after L. monocytogenes infection (Fig. 1A). These results suggest that L. monocytogenes infection induces IL-17A expression at very early stages in the infected liver.


Figure 1
View larger version (22K):
[in this window]
[in a new window]

  		FIGURE 1. Expression and function of IL-17A in the liver of L. monocytogenes-infected mice. A, Wild-type (WT) mice were infected via the intraperitoneal route with viable L. monocytogenes. IL-17A expression of liver mononuclear cells was analyzed by real time PCR method. The data are expressed as the increase in expression level compared with that before infection. The result shown is representative of three independent analyses. *, p < 0.05 compared with day 0. WT or IL-17A–/– mice were infected with viable L. monocytogenes, and bacterial burden in the liver was determined on day 1 and 5 after the infection (B), or liver mononuclear cells (MNC) were collected, and counted (C, left panel). The cells were stained with mAb against leukocyte surface molecules and analyzed by FCM. The ratio of neutrophils (Gr1+CD11b+) was determined and the absolute number of the cell was calculated (C, right panel). D, WT (open bar) or IL-17A–/– (filled bar) mice were inoculated with heat-killed L. monocytogenes, liver MNC were collected on day 5 of infection, and neutrophil number was determined. *, p < 0.05 compared with C57BL/6 mice. The analyses were conducted more than three times, and representative data is shown in this figure.

 
The importance of IL-17A in the innate immune response and in protection against L. monocytogenes infection

We analyzed the role of IL-17A in protection against L. monocytogenes infection during the innate immune response phase. To determine the contribution of IL-17A in the protective response against the infection, we first analyzed the bacterial burden in the liver of the L. monocytogenes-infected IL-17A–/– mice. As shown in Fig. 1B, bacterial counts in the liver of IL-17A–/– mice were more than 100 times higher than in wild-type mice on day 5 of the infection. These data demonstrate importance of IL-17A in the protective innate immune response against L. monocytogenes infection before acquired immunity is established.

Because IL-17A is known to induce neutrophils, we next analyzed the infiltrating cells in the liver of the IL-17A–/– mice by FACS after L. monocytogenes infection. The total number of the liver-infiltrating cells in IL-17A–/– mice was significantly higher than wild-type mice on day 5 of the infection, although the number was nearly the same as in wild-type mice on day 1. Unexpectedly, the number of neutrophils (Gr1highCD11b+ cells) was higher in the IL-17A–/– mice than that of wild-type mice, although IL-17A is a known neutrophil-inducing factor (Fig. 1C). It is possible that the increased bacterial burden in the liver of the IL-17A–/– mice (Fig. 1B) elicited higher numbers of neutrophils even in the absence of IL-17A. To address this, we analyzed the number of neutrophils in the liver 5 days after injection of heat killed L. monocytogenes. The data showed the number of neutrophils decreased in the IL-17A–/– mice compared with the wild-type mice (Fig. 1D). This suggests that the potential to induce neutrophils was decreased in the IL-17A–/– mice, but that higher number of neutrophils was induced after L. monocytogenes infection in the mice because of increased bacterial burden.

To analyze the influence of IL-17A on L. monocytogenes-induced early granuloma formation, a histological examination was conducted on the liver of infected IL-17A–/– and wild-type mice on day 5 of the infection. The wild-type mice showed small granulomatous lesions (Fig. 2A, upper panel) consisting of CD11b+ cells, possibly macrophages, surrounded by CD3+ T cells (Fig. 2B, upper panels). In contrast, the liver of the IL-17A–/– mice showed higher numbers of mononuclear cell-infiltrating lesions with larger size, irregular shape, and severe inflammatory cell infiltration (Fig. 2A, lower panels). This finding is consistent with the data in Fig. 1C showing increased numbers of infiltrating cells in the IL-17A–/– mice. The liver lesions of the infected IL-17A–/– mice showed scattered CD11b+ cells without an organized CD3+ T cell lining (Fig. 2B, lower panels), indicating that the formation of organized granulomatous lesions is impaired in the IL-17A–/– mice. Moreover, the outer perimeter of the lesions was surrounded by necrotic hepatocytes (Fig. 2A, lower panels), suggesting infection-induced liver injury in the IL-17A–/– mice. Increased liver injury was also indicated by an increase in serum ALT levels in the IL-17A–/– mice, but not in wild-type mice on day 5 of the infection (Fig. 2C). These results suggest that IL-17A is required not only in the protective response but also in the regulation of granuloma formation during the early stage of L. monocytogenes infection in the liver.


Figure 2
View larger version (97K):
[in this window]
[in a new window]

  		FIGURE 2. Pivotal role of IL-17A in the formation of granulomatous lesions at an early stage of L. monocytogenes infection. Mice were infected with L. monocytogenes and were sacrificed at day 5 of infection for histological examination. A, Sections of the liver of wild-type (WT) (upper panels) or IL-17A–/– (lower panels) mice were examined by H & E staining (original magnification x40 for left panels and x200 for right panels). B, Sections of WT (upper panels) or IL-17A–/– (lower panels) were examined by confocal laser scanning microscopy with CD11b mAb (green, left panels) and CD3 mAb (red, middle panels) staining (original magnification x200). Merged image of CD11b and CD3 staining are shown in the right panels. C, Kinetics of serum ALT levels after L. monocytogenes infection of WT ({circ}) or IL-17A–/– ({blacksquare}) mice is shown to indicate the degree of liver injury after the infection. *, p < 0.05 compared with wild-type mice. The data shown are representative of three independent experiments with more than five mice in each group.

 
The identification of IL-17A-producing cells at an early stage of L. monocytogenes infection

To determine the phenotype of IL-17A-producing cells at early stage L. monocytogenes infection, liver mononuclear cells were prepared from the wild-type mice on day 5 of infection, stained for cell surface markers and cytoplasmic IL-17A, and analyzed by FCM. As shown in Fig. 3A, TCR {gamma}{delta} T cells (TCR C{delta}+ cells) represented more than 80% of IL-17A-producing cells, whereas TCR {alpha}β T cells (TCR Cβ+ cells), which coexpress CD4, represented only 20% of the IL-17A-producing cells. No IL-17A production was detected in CD8+ T cells and NK1.1+ cells. The ratio of IL-17A-producing cells in the TCR {gamma}{delta}+ T cells (~20–34%) was higher than that in TCR {alpha}β+ T cells (less than 1%). Furthermore, the mean fluorescence intensity MFI of IL-17A staining of IL-17A+ TCR {gamma}{delta}+ T cells (MFI = 32.9) was higher than that of IL-17A+ TCR {alpha}β+ T cells (MFI = 11.8). Fig. 3B shows kinetics of IL-17-producing T cells in the liver after L. monocytogenes infection. The absolute number of IL-17+ TCR{gamma}{delta} T cells was higher on day 5 compared with day 1. In contrast, the absolute number of IL-17+ TCR {alpha}β T cells showed no significant difference between day 1 and 5 after the infection. This suggests increase of IL-17-producing TCR {gamma}{delta} T cells in the course of the L. monocytogenes infection and the T cells became a major IL-17-producing cells on day 5 of the infection.


Figure 3
View larger version (26K):
[in this window]
[in a new window]

  		FIGURE 3. Identification of IL-17A producing cells in the liver of L. monocytogenes-infected mice. Wild-type mice were infected with L. monocytogenes, and liver mononuclear cells were isolated. A, The liver mononuclear cells were analyzed on day 5 of the infection by FCM to identify IL-17A producing cells in the lymphocyte subsets, including TCR {gamma}{delta} T cells (TCR C{delta}+), {alpha}β T cells (TCR Cβ+), NK cells, NK T cells (NK1.1+), CD4+ T cells, and CD8+ T cells. B, The liver mononuclear cells were prepared on day 1 and 5 of the infection, and ratio and absolute number of IL-17-producing TCR Cβ+ or TCR C{delta}+ T cells were analyzed. *, p < 0.05. C, The liver mononuclear cells were prepared on day 5 of the infection and sorted into TCR {alpha}β+ or TCR {gamma}{delta}+ T cells. The cells were cultured in the culture dishes coated with anti-CD3 mAb (10 µg/ml) or not coated with mAb. Culture supernatants were collected 24 h later and IL-17A was detected by ELISA. D, TCR {gamma}{delta} T cells were sorted from the liver mononuclear cells on day 5 after the infection and analyzed by FCM for their expression of IL-17A and IFN-{gamma}. The experiments were repeated more than three times and a representative example is shown.

 
To further confirm contribution of the TCR {gamma}{delta} T cells in IL-17 production in the L. monocytogenes-infected liver on day 5 of the infection, we separated TCR {alpha}β+ and TCR {gamma}{delta}+ T cells from the liver mononuclear cells, stimulated them with anti-CD3 mAb, and analyzed IL-17 production by ELISA. As shown in Fig. 3C, a high level of IL-17 production was detected on the stimulated TCR {gamma}{delta} T cells but not on stimulated TCR {alpha}β T cells. All the results demonstrate that TCR {gamma}{delta} T cells are the major source of IL-17A production during the early stage of L. monocytogenes infection.

To analyze IL-17A-producing TCR {gamma}{delta} T cells in the liver in detail, we enriched TCR {gamma}{delta} T cells by magnetic sorting, and analyzed them by FACS. As shown in Fig. 3B, we confirmed that approximately one third of the TCR {gamma}{delta} T cells expressed IL-17A. When the enriched TCR {gamma}{delta} T cells were stained with Abs against IL-17A and IFN-{gamma}, IL-17A-producing cells and IFN-{gamma}-producing cells were segregated and only a minor fraction coexpressed both cytokines (Fig. 3D, right panel). Our data suggest that L. monocytogenes infection induces two TCR {gamma}{delta} T cell subpopulations characterized by their expression of IL-17A or IFN-{gamma}.

We previously reported that IFN-{gamma}-producing TCR {gamma}{delta} T cells are TCR V{gamma}1+ {gamma}{delta} T cells (15, 25). Because IFN-{gamma} producing TCR {gamma}{delta} T cells largely did not coproduce IL-17A (Fig. 3B), we reasoned that the IL-17A-producing TCR {gamma}{delta} T cells likely express V region genes other than V{gamma}1. To examine this, we analyzed the V region repertoire of the IL-17A-producing TCR {gamma}{delta} T cells in the liver of L. monocytogenes-infected mice. We first analyzed V{gamma} and V{delta} repertoire of the TCR {gamma}{delta} T cells induced in the liver of the L. monocytogenes-infected wild-type mice by RT-PCR. Fig. 4A shows expression of V{gamma}1 or 2, V{gamma}4 and V{gamma}6 as V{gamma} genes, and V{delta}1, V{delta}4, V{delta}5, and V{delta}6 as V{delta} genes by the TCR {gamma}{delta} T cells. Because mAb against V{gamma}1, V{gamma}4, and V{gamma}5 were available, we next analyzed V{gamma} usage of the IL-17A-producing TCR {gamma}{delta} T cells by FCM. Fig. 4B shows a representative FACS profile of the V{gamma} staining of the liver TCR {gamma}{delta} T cells on day 5 of the L. monocytogenes infection. IL-17A-producing TCR {gamma}{delta} T cells could be hardly detected among V{gamma}1+ T cells. In contrast, more than 30% of TCR V {gamma}4+ {gamma}{delta} T cells were IL-17A-producing T cells. TCR V{gamma}5+ {gamma}{delta} T cells were not detected (data not shown), which is consistent with the data of RT-PCR (Fig. 4A). It has been reported that a mAb 17D1 raised against V{gamma}5/V{delta}1+ TCR {gamma}{delta} T cells also recognizes V{gamma}6/V{delta}1+ TCR {gamma}{delta} T cells when prestained with anti-TCR C{delta} mAb (27). Because the liver TCR {gamma}{delta} T cells contained no V{gamma}5+ TCR {gamma}{delta} T cells, TCR C{delta}+ 17D1+ cells are TCR V{gamma}6+ {gamma}{delta} T cells in the liver. The TCR V{gamma}6+ TCR {gamma}{delta} T cells detected with the 17D1 mAb contained 10–15% of IL-17A-expressing cells.


Figure 4
View larger version (48K):
[in this window]
[in a new window]

  		FIGURE 4. Restricted TCR V{gamma} repertoire of IL-17A-producing TCR {gamma}{delta} T cells. A, Wild-type (WT) mice were infected with L. monocytogenes, liver mononuclear cells on day 5 were isolated, and TCR {gamma}{delta} T cells were enriched using the MACS system. The TCR V{gamma} and V{delta} repertoire of the {gamma}{delta} T cells was analyzed by PCR and agarose gel electrophoresis. B, IL-17A-producing TCR {gamma}{delta} T cell subpopulations were analyzed in the liver mononuclear cells on day 5 of L. monocytogenes-infected WT mice by FCM using anti-V{gamma} mAb after analysis gate was set on TCR C{delta}+ cells (lower panels). The data shown are representative of two or three independent experiments. C, The liver mononuclear cells were collected on day 1 or 5 after the infection and analyzed for V{gamma} expression and IL-17 production as in B. Three samples consisting of pooled liver mononuclear cells of two to three mice were analyzed and mean and SD was plotted. D, IL-17A production of TCR {gamma}{delta} T cells was also analyzed in the liver mononuclear cells of L. monocytogenes-infected V{gamma}4/6–/– mice on day 5 by FCM after analysis gate was set on TCR C{delta}+ cells. E, Sections of the liver of WT (upper panels) or V{gamma}4/6–/– (lower panels) mice were examined by H & E staining (original magnification x40 for left panels and x200 for right panels).

 
We further analyzed V{gamma} repertoire and IL-17 expression of each V{gamma} subpopulation of the liver TCR {gamma}{delta} T cells on day 1 and 5 after L. monocytogenes infection. As summarized in Fig. 4C, nearly 80% of the liver TCR {gamma}{delta} T cells expressed V{gamma}4 on day 1 of the infection, and the V{gamma}4+ TCR {gamma}{delta} T cells were the major IL-17-producing TCR {gamma}{delta} T cells. On day 5 of the infection, the ratio of the V{gamma}6+ {gamma}{delta} T cells increased to nearly the same level as the V{gamma}4+ TCR {gamma}{delta} T cells, and IL-17+ TCR V{gamma}6+ {gamma}{delta} T cells became detectable.

To confirm the contribution of the TCR V{gamma}4+ and TCR V{gamma}6+ {gamma}{delta} T cells in IL-17A production at an early stage of L. monocytogenes infection, we examined the liver {gamma}{delta} T cells sorted from the TCR V{gamma}4/6–/– mice after L. monocytogenes infection. The TCR {gamma}{delta} T cells from the infected V{gamma}4/6–/– mice failed to produce IL-17A (Fig. 4D). The lack of IL-17-producing TCR {gamma}{delta} T cells was not compensated by IL-17-producing TCR {alpha}β T cells. Furthermore, V{gamma}4/6–/– mice also showed large inflammatory lesions in the liver on day 5 of the L. monocytogenes infection (Fig. 4E). Taking these results together, we concluded that TCR V{gamma}4+ and V{gamma}6+ {gamma}{delta} T cells are the two major IL-17A-producing TCR {gamma}{delta} T cell populations in the liver at an early stage of L. monocytogenes infection.

TCR {gamma}{delta} T cells producing IL-17A are essential for early protection against L. monocytogenes infection

Although we already demonstrated the importance of IL-17A in the early protection against L. monocytogenes infection (Fig. 3A), this did not prove that IL-17A-producing TCR {gamma}{delta} T cells actually contribute to the IL-17A-mediated early protection. To directly test this, we reconstituted irradiated IL-17A–/– mice with BM cells from wild-type, TCR C{delta}–/–, or IL-17A–/– mice, and compared their ability to contain L. monocytogenes in early infection. IL-17A–/– mice reconstituted with IL-17A–/– BM cells lack IL-17A-producing cells, and showed a significantly higher level of bacterial burden in the liver on day 5 of the infection compared with that of the IL-17A–/– mice reconstituted with wild-type BM cells (Fig. 5). The IL-17A–/– mice reconstituted with the BM cells of TCR C{delta} –/– mice showed a significantly higher bacterial burden in the liver than did IL-17A–/– mice reconstituted with wild-type BM cells, although IL-17A-producing cells other than TCR {gamma}{delta} T cells can develop in the former mice (Fig. 5). These results suggest importance of TCR {gamma}{delta} T cells in early protection against L. monocytogenes infection. To further prove the contribution of IL-17A derived from TCR {gamma}{delta} T cells, we reconstituted IL-17A–/– mice with BM cells from both C{delta}–/– and IL-17A–/– mice. In the mixed BM chimera mice reconstituted with IL-17A–/– and C{delta}–/– BM cells, IL-17A-expressing cells can develop from C{delta}–/– BM cells, and TCR {gamma}{delta} T cells can develop from IL-17A–/– BM. Therefore, they lack IL-17A-producing TCR {gamma}{delta} T cells but retain IL-17A-producing TCR {alpha}β T cells and IL-17A-non-producing {gamma}{delta} T cells. The mixed BM chimera mice showed a significantly higher bacterial burden in the liver than did IL-17A–/– mice reconstituted with wild-type BM cells. All the results demonstrate that TCR {gamma}{delta} T cells producing IL-17A play an important role in protection during the early stage of L. monocytogenes infection.


Figure 5
View larger version (15K):
[in this window]
[in a new window]

  		FIGURE 5. TCR {gamma}{delta} T cells producing IL-17A contribute to early protection against L. monocytogenes infection. Irradiated IL-17A–/– mice were transplanted with BM cells from wild-type (WT), IL-17A–/–, TCRC{delta}–/–, and both IL-17A–/– and TCRC{delta}–/– mice (BM chimeras). BM chimeras were infected i.p. with L. monocytogenes 35 days after the transfer. The bacterial burden was determined on day 5 of the infection. *, p less double equals 0.05. The data shown is a representative of two independent experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
In the present study, we examined the role of IL-17A in innate immunity against L. monocytogenes infection in the liver. Our data demonstrate that TCR {gamma}{delta} T cells producing IL-17A play a pivotal role in protection during the early stage of infection. Furthermore, IL-17A also enhances the anti-bacterial activity of L. monocytogenes-infected non-phagocytic cells, which correlated with induction of anti-microbial peptide mouse β-defensin (mBD) gene expression. These results indicate that a newly discovered IL-17A-dependent protective mechanism of TCR {gamma}{delta} T cells acts against intracellular bacterial infection in the liver.

Recently, a new lineage of effector CD4+ T cells, Th17, was reported to produce IL-17A and belong to a unique lineage distinct from classical Th1 and Th2 cells (9, 10, 11, 12). The IL-17A-producing TCR {gamma}{delta} T cells in this study share several important characteristics with the Th17 cells. First, the IL-17A-producing TCR {gamma}{delta} T cells and IFN-{gamma}-producing TCR {gamma}{delta} T cells represent distinct subsets (Fig. 3B) just as do Th1 and Th17 cells. The TCR V{gamma} repertoire of IFN-{gamma}-producing and IL-17A-producing TCR {gamma}{delta} T cells is also different because the former express V{gamma}1 (15) whereas the latter express V{gamma}4 or V{gamma}6 (Fig. 4). Second, IL-23 is required for IL-17A production by Th17 and TCR {gamma}{delta} T cells. The expression of IL-17A in the liver disappeared in the L. monocytogenes-infected IL-12/23 p40-deficient mice (S.H., unpublished observation), suggesting the importance of IL-23 in the induction of IL-17A expression by TCR {gamma}{delta} T cells. Furthermore, stimulation with IL-23 alone induced a low level of IL-17A production by naive TCR {gamma}{delta} T cells (28). Therefore, the development of the IL-17A-producing TCR {gamma}{delta} T cells may be regulated by molecules such as TGF-β, IL-6, and ROR-{gamma}t, which regulate Th17 cells. Analysis of the developmental pathway of the IL-17A-producing TCR {gamma}{delta} T cells is now ongoing using a thymus organ culture system.

The importance of TCR {gamma}{delta} T cells in the early protection against L. monocytogenes has been reported (29, 30, 31, 32). TCR {gamma}{delta} T cell-deficient mice showed increased bacterial burden after L. monocytogenes infection. Furthermore, the TCR {gamma}{delta} T cell-deficient mice showed large inflammatory lesions in the liver with necrotic hepatocytes (31, 32), which is indistinguishable from those observed in the IL-17A–/– mice. Therefore, we estimate that characteristic lesions of the L. monocytogenes-infected TCR {gamma}{delta} T cell-deficient mice develop in the absence of IL-17A mainly produced by the TCR {gamma}{delta} T cells. However, the protective role of TCR {gamma}{delta} T cell subsets is controversial. A report showed importance of IFN-{gamma}-producing TCR V{gamma}1+ {gamma}{delta} T cells in intraperitoneal infection system (15), whereas another showed TCR V{gamma}1–V{gamma}4– {gamma}{delta} T cells are important in i.v. infection system (33). In the latter report, it was demonstrated that deletion of TCR V{gamma}1+ {gamma}{delta} T cells from wild-type C57BL/10 mice enhanced bacterial elimination, whereas TCR {gamma}{delta} T cell-depleted mice or TCR {gamma}{delta} T cell-deficient mice showed a significant increase in bacterial numbers in the infected organs. It may be possible to explain this observation by mutual regulation of the IFN-{gamma}-producing TCR V{gamma}1+ {gamma}{delta} T cells and IL-17A-producing TCR V{gamma}4/6+ {gamma}{delta} T cells. In the absence of IFN-{gamma}-producing TCR V{gamma}1+ {gamma}{delta} T cells, the protective response by the IL-17A-producing TCR V{gamma}4/6+ {gamma}{delta} T cells may be enhanced. The possibility is now under investigation.

Although IL-17A is generally accepted as a cytokine of acquired immunity produced by Th17 cells, our data demonstrate that IL-17A is also an important cytokine in innate immunity. IL-17A has been previously reported to participate in the immune response against various infections at an early stage of the response. We demonstrate in this report that the TCR {gamma}{delta} T cells express IL-17A at an early stage of L. monocytogenes infection, and contribute to early protection. We recently reported that M. bovis BCG infection in the lung of mice induced IL-17A-producing TCR {gamma}{delta} T cells within 3 days of the infection (7). Intraperitoneal infection of Escherichia coli also induced IL-17A producing TCR {gamma}{delta} T cells within 6 h after infection (28). In the K. pneumoniae lung infection of the wild-type mice, IL-17A was induced within 18 h after infection (34), and infection of the IL-17A receptor-deficient mice with K. pneumoniae resulted in decreased survival and increased bacterial burden from day 2 of the infection (35). Candida albicans-infected IL-17A receptor-deficient mice also showed decreased survival and increased fungal burden from day 3 after the infection (6). Furthermore, i.p. inoculation of Bacteroides fragilis induced IL-17A expression within 24 h (36). Although the IL-17A-producing cells in the K. pneumoniae-infected mice were CD4+ and CD8+ T cells (37), these responses must be considered as innate immune responses rather than Ag-specific Th17 responses, because their responses were observed before a conventional Ag-specific T cell response could be established during primary antigenic stimulation. It is possible that IL-17A production at an early stage of infection is induced by the stimulation of IL-23 produced by pathogen-activated macrophages/dendritic cells. Consistent with this hypothesis, IL-23 induced by TLR4-mediated signaling induced IL-17A production by TCR V{delta}1+ {gamma}{delta} T cells in the E. coli-infected peritoneal cavity (28). LPS from Salmonella also induced IL-17A expression at an early stage after inoculation (38). Therefore, the IL-17A-producing T cells that respond at an early stage of infection, including TCR {gamma}{delta} T cells, could be activated quickly after invasion of the pathogen, through the IL-23 produced by pathogen-activated macrophages/dendritic cells (39).

IL-17A has been reported to be expressed by several T cell subpopulations, including TCR {alpha}β+ CD4+, CD8+, or CD4–CD8– cells and TCR {gamma}{delta}+ T cells. We have identified TCR {gamma}{delta} T cells and CD4–CD8– TCR {alpha}β T cells as FasL-induced IL-17A-producing cells (13). Stark et al. also identified IL-17A-producing TCR {gamma}{delta} T cells and TCR {alpha}βlow CD4–CD8– T cells in adhesion molecule-deficient CD18–/– and selectin–/– mice, and proposed to call them Tn cells for "neutrophil regulatory T cells" (14). In the L. monocytogenes-infected mice, we detected IL-17A on not only TCR {gamma}{delta}+"Tn" cells but TCR {alpha}β+CD4+ T cells at an early stage of infection. However, our analysis of BM chimeric mice suggests that IL-17A-producing TCR {gamma}{delta} T cells are more important in anti-listerial protection than the IL-17A-producing CD4+ T cells. In contrast, IL-17A-producing CD4+ T cells are reported to be important in the early protection against K. pneumoniae infection. Difference in the localization of the bacteria (intracellular for L. monocytogenes vs extracellular for K. pneumoniae) or in expression of ligands recognized by the innate immune system could be the cause of this difference. Further investigation is required to clarify this issue.

Our data suggest that IL-17A produced at an early stage of L. monocytogenes infection enhances early protection. It was reported that Th17 cells coexpress IL-22, and that IL-17A and IL-22 cooperatively induced expression of anti-microbial peptides including β-defensins and S100A8/9 molecules (40). We also observed expression of IL-22, mBD-2, and mBD-3 in the L. monocytogenes-infected liver, which was markedly diminished in the IL-17A deficient mice (S.H. and G.M., unpublished observation). mBD-3 has been reported to display a broad spectrum of antimicrobial activity against Gram-negative and Gram-positive bacteria and fungi (41, 42), and the human homologue of mBD-3 (human BD-2) efficiently killed L. monocytogenes (43). Although defensins are generally accepted as secretory proteins, it was reported that human BD-2 colocalized with intracellular M. tuberculosis in non-phagocytic type II alveolar epithelial cells, which seems to result in disruption of the intracellular bacteria (44). We estimate that colocalization of mBD-3 and intracellular L. monocytogenes and subsequent bacterial elimination may occur in the L. monocytogenes-infected hepatocytes in response to IL-17 and IL-22.

It was recently reported that IL-22 protects hepatocytes from ConA-induced injury while bacterial burden in L. monocytogenes-infected IL-22-deficient mice was at the same level as that of wild-type mice (45). Importance of IL-22 in bacterial elimination and maintenance of tissue integrity have recently been reported in the infection of K. pneumoniae (46) and Citrobacter rodentium (47). Therefore, importance of IL-17A/IL-22 system in the infection may have to be considered from both elimination of pathogens and from protection against tissue injury.


   Acknowledgments
 
We thank Dr. Pablo Pereira for 2.11 mAb.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aids for Scientific Research from Japan Society for Promotion of Science, and a grant from Takeda Science Foundation. Back

2 Address correspondence and reprint requests to Dr. Goro Matsuzaki, Molecular Microbiology Group, Center of Molecular Biosciences, University of the Ryukyus, Senbaru 1, Nishihara, Okinawa 903-01213, Japan. E-mail address: matsuzak{at}comb.u-ryukyu.ac.jp Back

3 Abbreviations used in this paper: BM, bone marrow; mBD, mouse β-defensin; ALT, alanine aminotransferase; MFI, mean fluorescence intensity. Back

Received for publication November 15, 2007. Accepted for publication June 12, 2008.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914. [Abstract/Free Full Text]
  2. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725. [Medline]
  3. Kolls, J. K., A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-746. [Medline]
  4. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. [Abstract/Free Full Text]
  5. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202: 761-769. [Abstract/Free Full Text]
  6. Huang, W., L. Na, P. L. Fidel, P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631. [Medline]
  7. Umemura, M., A. Yahagi, S. Hamada, M. D. Begum, H. Watanabe, K. Kawakami, T. Suda, K. Sudo, S. Nakae, Y. Iwakura, G. Matsuzaki. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacilli Calmette-Guerin infection. J. Immunol. 178: 3786-3796. [Abstract/Free Full Text]
  8. Lockhart, E., A. M. Green, J. L. Flynn. 2006. IL-17 production is dominated by {gamma}{delta} T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662-4669. [Abstract/Free Full Text]
  9. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132. [Medline]
  10. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. [Medline]
  11. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, C. T. Weaver. 2006. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441: 231-234. [Medline]
  12. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, B. Stockinger. 2006. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. [Medline]
  13. Umemura, M., T. Kawabe, K. Shudo, H. Kidoya, M. Fukui, M. Asano, Y. Iwakura, G. Matsuzaki, R. Imamura, T. Suda. 2004. Involvement of IL-17 in Fas ligand-induced inflammation. Int. Immunol. 16: 1099-1108. [Abstract/Free Full Text]
  14. Stark, M. A., Y. Huo, T. L. Burcin, M. A. Morris, T. S. Olson, K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-294. [Medline]
  15. Matsuzaki, G., H. Yamada, K. Kishihara, Y. Yoshikai, K. Nomoto. 2002. Mechanism of murine V{gamma}1+ {gamma}{delta} T cell-mediated innate immune response against Listeria monocytogenes infection. Eur. J. Immunol. 32: 928-395. [Medline]
  16. Huber, S., C. Shi, R. C. Budd. 2002. {gamma}{delta} T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J. Virol. 76: 6487-6494. [Abstract/Free Full Text]
  17. Carding, S. R., P. J. Egan. 2002. {gamma}{delta} T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2: 336-345. [Medline]
  18. Hsieh, B., M. D. Schrenzel, T. Mulvania, H. D. Lepper, L. DiMolfetto-Landon, D. A. Ferrick. 1996. In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by {gamma}{delta} T cells. J. Immunol. 156: 232-237. [Abstract]
  19. Inagaki-Ohara, K., T. Chinen, G. Matsuzaki, A. Sasaki, Y. Sakamoto, K. Hiromatsu, F. Nakamura-Uchiyama, Y. Nawa, A. Yoshimura. 2004. Mucosal T cells bearing TCR {gamma}{delta} play a protective role in intestinal inflammation. J. Immunol. 173: 1390-1398. [Abstract/Free Full Text]
  20. Nagaeva, O., L. Jonsson, L. Mincheva-Nilsson. 2002. Dominant IL-10 and TGF-β mRNA expression in {gamma}{delta} T cells of human early pregnancy decidua suggest immunoregulatory potential. Am. J. Reprod. Immunol. 48: 9-17. [Medline]
  21. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387. [Medline]
  22. Itohara, S., P. Mombaerts, J. Lafaille, J. Iacomini, A. Nelson, A. R. Clarke, M. L. Hooper, A. Farr, S. Tonegawa. 1993. T cell receptor {delta} gene mutant mice: independent generation of {alpha}βT cells and programmed rearrangements of {gamma}{delta} TCR genes. Cell 72: 337-348. [Medline]
  23. Sunaga, S., K. Maki, Y. Komagata, Y. Miyazaki, K. Ikuta. 1997. Developmentally ordered V-J recombination in mouse T cell receptor {gamma} locus is not perturbed by targeted deletion of the V{gamma}4 gene. J. Immunol. 158: 4223-4228. [Abstract]
  24. Goossens, P. L., H. Jouin, G. Marchal, G. Milon. 1990. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J. Immunol. Methods 132: 137-144. [Medline]
  25. Matsuzaki, G., K. Hiromatsu, Y. Yoshikai, K. Muramori, K. Nomoto. 1993. Characterization of T-cell receptor {gamma}{delta} T cells appearing at the early phase of murine Listeria monocytogenes infection. Immunology 78: 22-27. [Medline]
  26. Heilig, J. S., S. Tonegawa. 1986. Diversity of murine {gamma} genes and expression in fetal and adult T lymphocytes. Nature 322: 836-840. [Medline]
  27. Roark, C. E., M. Kermal Aydintug, J. Lewis, X. Yin, M. Lahn, Y. Hahn, W. K. Born, R. E. Tigelaar, R. L. O'Brien. 2004. Subset-specific, uniform activation among V{gamma}6/V{delta}1+ {gamma}{delta} T cells elicited by inflammation. J. Leukocyte Biol. 75: 68-75. [Abstract/Free Full Text]
  28. Shibata, K., H. Yamada, H. Hara, K. Kishihara, Y. Yoshikai. 2007. Resident V{delta}1+ {gamma}{delta} T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178: 4466-4472. [Abstract/Free Full Text]
  29. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Muramori, K. Matsumoto, J. A. Bluestone, K. Nomoto. 1992. A protective role of {gamma}{delta} T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175: 49-56. [Abstract/Free Full Text]
  30. Skeen, M. J., H. K. Ziegler. 1993. Induction of murine peritoneal {gamma}/{delta} T cells and their role in resistance to bacterial infection. J. Exp. Med. 178: 971-984. [Abstract/Free Full Text]
  31. Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, S. H. Kaufmann. 1993. Different roles of {alpha}β and {gamma}{delta} T cells in immunity against an intracellular bacterial pathogen. Nature 365: 53-56. [Medline]
  32. Fu, Y. X., C. E. Roark, K. Kelly, D. Drevets, P. Campbell, R. O'Brien, W. Born. 1994. Immune protection and control of inflammatory tissue necrosis by {gamma}{delta} T cells. J. Immunol. 153: 3101-3115. [Abstract]
  33. O'Brien, R. L., X. Yin, S. A. Huber, K. Ikuta, W. K. Born. 2000. Depletion of a {gamma}{delta} T cell subset can increase host resistance to a bacterial infection. J. Immunol. 165: 6472-6479. [Abstract/Free Full Text]
  34. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340. [Abstract/Free Full Text]
  35. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527. [Abstract/Free Full Text]
  36. Chung, D. R., D. L. Kasper, R. J. Panzo, T. Chitnis, M. J. Grusby, M. H. Sayegh, A. O. Tzianabos. 2003. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170: 1958-1963. [Abstract/Free Full Text]
  37. Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, J. K. Kolls. 2003. Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436. [Abstract/Free Full Text]
  38. Ferretti, S., O. Bonneau, G. R. Dubois, C. E. Jones, A. Trifilieff. 2003. IL-17 produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170: 2106-2112. [Abstract/Free Full Text]
  39. Matsuzaki, G., M. Umemura. 2007. Interleukin-17 as an effecter molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51: 1139-1147. [Medline]
  40. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279. [Abstract/Free Full Text]
  41. Burd, R. S., J. L. Furrer, J. Sullivan, A. L. Smith. 2002. Murine β-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock 18: 461-464. [Medline]
  42. Bals, R., X. Wang, R. L. Meegalla, S. Wattler, D. J. Weiner, M. C. Nehls, J. M. Wilson. 1999. Mouse β-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect. Immun. 67: 3542-3547. [Abstract/Free Full Text]
  43. Lopez-Solanilla, E., B. Gonzalez-Zorn, S. Novella, J. A. Vazquez-Boland, P. Rodriguez-Palenzuela. 2003. Susceptibility of Listeria monocytogenes to antimicrobial peptides. FEMS Microb. Lett. 226: 101-105. [Medline]
  44. Rivas-Santiago, B., S. K. Schwander, C. Sarabia, G. Diamond, M. E. Klein-Patel, R. Hernandez-Pando, J. J. Ellner, E. Sada. 2005. Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect. Immun. 73: 4505-4511. [Abstract/Free Full Text]
  45. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. D. Murphy, M. Karow, R. A. Flavell. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659. [Medline]
  46. Aujla, A. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281. [Medline]
  47. Zhen, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289. [Medline]



This article has been cited by other articles:


Home page
 Infect. Immun.Home page
X. Zhou, Q. Chen, J. Moore, J. K. Kolls, S. Halperin, and J. Wang
Critical Role of the Interleukin-17/Interleukin-17 Receptor Axis in Regulating Host Susceptibility to Respiratory Infection with Chlamydia Species
Infect. Immun., November 1, 2009; 77(11): 5059 - 5070.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. M. S. Algood, S. S. Allen, M. K. Washington, R. M. Peek Jr., G. G. Miller, and T. L. Cover
Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection
J. Immunol., November 1, 2009; 183(9): 5837 - 5846.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Paidipally, S. Periasamy, P. F. Barnes, R. Dhiman, M. Indramohan, D. E. Griffith, D. Cosman, and R. Vankayalapati
NKG2D-Dependent IL-17 Production by Human T Cells in Response to an Intracellular Pathogen
J. Immunol., August 1, 2009; 183(3): 1940 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. von Vietinghoff and K. Ley
IL-17A Controls IL-17F Production and Maintains Blood Neutrophil Counts in Mice
J. Immunol., July 15, 2009; 183(2): 865 - 873.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Curtis, S. S. Way, and C. B. Wilson
IL-23 Promotes the Production of IL-17 by Antigen-Specific CD8 T Cells in the Absence of IL-12 and Type-I Interferons
J. Immunol., July 1, 2009; 183(1): 381 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Nistala and L. R. Wedderburn
Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
Rheumatology, June 1, 2009; 48(6): 602 - 606.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. L. Simonian, C. L. Roark, F. Wehrmann, A. M. Lanham, W. K. Born, R. L. O'Brien, and A. P. Fontenot
IL-17A-Expressing T Cells Are Essential for Bacterial Clearance in a Murine Model of Hypersensitivity Pneumonitis
J. Immunol., May 15, 2009; 182(10): 6540 - 6549.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. D. Joshi, D. J. Fong, S. R. Oak, G. Trujillo, K. R. Flaherty, F. J. Martinez, and C. M. Hogaboam
Interleukin-17-mediated Immunopathogenesis in Experimental Hypersensitivity Pneumonitis
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 705 - 716.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamada, S.
Right arrow Articles by Matsuzaki, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamada, S.
Right arrow Articles by Matsuzaki, G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS